Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Sax

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cell Reports. Medicine|May 11, 2022
Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccineTomohiro Takano, Miwa Morikawa, Yu Adachi, et al.
The Journal of Experimental Medicine|October 8, 2021
Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related virusesRyo Shinnakasu, Shuhei Sakakibara, Hiromi Yamamoto, et al.
Science Advances|June 14, 2023
CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopesTaishi Onodera, Nicolas Sax, Takashi Sato, et al.
Cell Reports|February 2, 2022
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypesJoji Nagasaki, Takashi Inozume, Nicolas Sax, et al.
The Journal of Experimental Medicine|October 14, 2021
Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patientsXiuyuan Lu, Yuki Hosono, Masamichi Nagae, et al.
Cancer Research Communications|March 16, 2023
Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune InfiltrationTakao Morinaga, Takashi Inozume, Masahito Kawazu, et al.
Gastroenterology|October 23, 2021
HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite InstabilityMasahito Kawazu, Toshihide Ueno, Koichi Saeki, et al.
Science Advances|May 19, 2023
Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8<sup>+</sup> T cell cytotoxicity and proliferationYujiro Naito, Shohei Koyama, Kentaro Masuhiro, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cell Reports. Medicine|May 11, 2022
Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccineTomohiro Takano, Miwa Morikawa, Yu Adachi, et al.
The Journal of Experimental Medicine|October 8, 2021
Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related virusesRyo Shinnakasu, Shuhei Sakakibara, Hiromi Yamamoto, et al.
Science Advances|June 14, 2023
CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopesTaishi Onodera, Nicolas Sax, Takashi Sato, et al.
Cell Reports|February 2, 2022
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypesJoji Nagasaki, Takashi Inozume, Nicolas Sax, et al.
The Journal of Experimental Medicine|October 14, 2021
Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patientsXiuyuan Lu, Yuki Hosono, Masamichi Nagae, et al.
Cancer Research Communications|March 16, 2023
Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune InfiltrationTakao Morinaga, Takashi Inozume, Masahito Kawazu, et al.
Gastroenterology|October 23, 2021
HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite InstabilityMasahito Kawazu, Toshihide Ueno, Koichi Saeki, et al.
Science Advances|May 19, 2023
Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8<sup>+</sup> T cell cytotoxicity and proliferationYujiro Naito, Shohei Koyama, Kentaro Masuhiro, et al.
Pageof 2